Accuracy of clinical diagnosis of progressive supranuclear palsy.
about
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS studyIdentification of common variants influencing risk of the tauopathy progressive supranuclear palsy.Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients.Primary lateral sclerosis as progressive supranuclear palsy: diagnosis by diffusion tensor imaging.Magnetic resonance imaging in progressive supranuclear palsy.Freezing of gait is an early clinical feature of progressive supranuclear palsy.Morphometric analysis of subcortical structures in progressive supranuclear palsy: In vivo evidence of neostriatal and mesencephalic atrophy.Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysisSpecificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy.Medical Record Review to Differentiate between Idiopathic Parkinson's Disease and Parkinsonism: A Danish Record Linkage Study with 10 Years of Follow-Up.Criteria for the diagnosis of corticobasal degenerationValidation of hospital register-based diagnosis of Parkinson's disease.Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes.What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?Visual hallucinations in the differential diagnosis of parkinsonism.Interhemispheric inhibition in different phenotypes of progressive supranuclear palsy.Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy.Fifty years of progressive supranuclear palsy.Sleep Disorders in Atypical Parkinsonism.The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.How do patients with parkinsonism present? A clinicopathological study.Which ante mortem clinical features predict progressive supranuclear palsy pathology?Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.Imaging tau pathology in Parkinsonisms.Spinocerebellar degeneration: Discrepancies between clinical and pathological diagnoses.Quality of life in patients with progressive supranuclear palsy: one-year follow-up.Differential pattern of brain-specific CSF proteins tau and amyloid-β in Parkinsonian syndromes.Symptom prevalence, severity and palliative care needs assessment using the Palliative Outcome Scale: a cross-sectional study of patients with Parkinson's disease and related neurological conditions.Magnetic resonance support vector machine discriminates between Parkinson disease and progressive supranuclear palsy.Role of magnetic resonance planimetry and magnetic resonance parkinsonism index in discriminating Parkinson's disease and progressive supranuclear palsy: a retrospective study based on 1.5 and 3 T MRI.Positron emission tomography imaging of tau pathology in progressive supranuclear palsy.Hypodipsia discriminates progressive supranuclear palsy from other parkinsonian syndromes.Basal ganglia cellular pathology in multiple system atrophy, progressive supranuclear palsy and Parkinson disease. Can quantitative magnetic resonance spectroscopic imaging make the difference?Manual MRI morphometry in Parkinsonian syndromes.A novel computer-assisted image analysis of [123I]β-CIT SPECT images improves the diagnostic accuracy of parkinsonian disorders.Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes.Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy.Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease.Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy.Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases
P2860
Q24655620-29A9FA5B-00AB-4ECD-99F5-57478B9856EEQ29417026-A70B0C23-890C-48D4-9BD5-CACBCBB9CBB0Q30454798-AFE51837-8364-4716-9F1B-B88236A4E038Q30518016-EB2EDC93-B4C7-4B57-86EC-05669D442C59Q33779124-23BD2267-CBEA-48FB-AD5F-D3317E087E71Q33835563-DA12862C-A9E5-43E3-AD72-96A243E61347Q35479731-BB3D52AB-4510-487A-A942-DA86FE280667Q36198606-7493A933-6C41-4F6F-A727-4664996BFD66Q36354065-3D879EA9-9D71-49AE-91E7-B59D9A20C59FQ36378714-B3F67E31-3149-4536-ACD7-854DA31922E6Q36661843-3F2A2457-3F1F-4FB7-A139-6631629FBE02Q36815107-78D391AD-3CCB-4DCB-A1E0-182F6327559BQ37185684-E4F1C0BB-6E32-41E7-A12A-AF023C5614F5Q37682763-79150832-7238-49CC-819C-3D0AB658B9ABQ37974179-116C09AF-F1ED-47C8-A7AB-36A3C313118DQ38034649-A18A514B-3A92-4258-997C-C599C0C34D86Q38084252-EA01709B-9B5A-446C-B379-0D10DF0A795BQ38135221-C39395CA-A99D-4835-960F-E0D312E471CCQ38222443-BBEAFDC1-48CF-49BC-8CE0-AAA16EFEFCEDQ38265061-8FBFE133-076D-4C9C-AEA4-D9B1072EF458Q38426881-DFD5A0D5-4E78-4695-A66D-EC9D3769E2D7Q38788274-9B6F1A07-DA39-43EE-AAC8-EC7080C31C0DQ38807324-48BACE83-9BE5-4437-AC2F-A6B11D805712Q39419877-47821164-6EB2-4C53-8812-BBDF5300212CQ40335111-A59CAC9F-D7B6-4C0A-972D-D867D8142965Q41674282-543BB636-6574-43C3-86AC-F157294928F4Q44298571-F90874C3-26E1-4D9F-85F9-68C8993BDE15Q45403564-1A455B49-9C48-4922-A19E-CD6275900037Q45958089-9D6C60C7-C6A4-4D58-BC57-4571EB818021Q47118856-E9D9C2E9-462B-4F9B-B2E0-D00E3CD11169Q47809826-8BEB7AE0-1CB9-46A1-B68F-1CD7219E0802Q48149489-2E2F5182-6C63-4C6E-AF8B-896EDBAFF318Q48160114-42755632-2F07-4DF8-AF99-F087D4A2866BQ48285702-74879CAC-A601-4ED7-A594-9878E3F51E8CQ48303226-1B32EFAC-4172-4AD9-B393-A781D522A89EQ48748866-1F15C5CC-F8BA-4655-BA16-3C43A7CD7BA8Q50567708-A907BCB8-6234-42A1-AEFC-5AD354E2EFA7Q50780829-4C42EE73-B727-4D17-AF4B-A141F34F4D76Q51679963-75E12796-AB08-4B1C-8295-E3E8C7D5DB88Q57605565-BC69087B-AE37-4D5A-B483-41C5D9AC7805
P2860
Accuracy of clinical diagnosis of progressive supranuclear palsy.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Accuracy of clinical diagnosis of progressive supranuclear palsy.
@ast
Accuracy of clinical diagnosis of progressive supranuclear palsy.
@en
type
label
Accuracy of clinical diagnosis of progressive supranuclear palsy.
@ast
Accuracy of clinical diagnosis of progressive supranuclear palsy.
@en
prefLabel
Accuracy of clinical diagnosis of progressive supranuclear palsy.
@ast
Accuracy of clinical diagnosis of progressive supranuclear palsy.
@en
P2093
P2860
P50
P356
P1433
P1476
Accuracy of clinical diagnosis of progressive supranuclear palsy.
@en
P2093
Susan E Daniel
Yasushi Osaki
Yoav Ben-Shlomo
P2860
P304
P356
10.1002/MDS.10680
P407
P577
2004-02-01T00:00:00Z